Characteristics and outcomes of patients with carcinoma in situ only at radical cystectomy

Urology

Volumn 68, Issue 3, 2006, Pages 538-542

  Shariat, Shahrokh F ^a   Palapattu, Ganesh S ^b   Amiel, Gilad E ^c   Karakiewicz, Pierre I ^d   Rogers, Craig G ^b   Vazina, Amnon ^c   Schoenberg, Mark P ^b   Lerner, Seth P ^c   Sagalowsky, Arthur I ^a   Lotan, Yair ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER CONTROL; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CARCINOMA IN SITU; CONFIDENCE INTERVAL; CYSTECTOMY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA IN SITU; CYSTECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 33748930612     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.03.033     Document Type: Article

References (18)

1. Lamm D.L. Carcinoma in situ. Urol Clin North Am 19 (1992) 499-508
2. Witjes J.A. Bladder carcinoma in situ in 2003: state of the art. Eur Urol 45 (2004) 142-146
3. Sylvester R.J., van der Meijden A.P., Witjes J.A., et al. Bacillus Calmette-Guérin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials. J Urol 174 (2005) 86-92
4. Sylvester R.J., van der Meijden A., and Lamm D.L. Intravesical bacillus Calmette-Guérin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol 168 (2002) 1964-1970
5. Stein J.P. Indications for early cystectomy. Urology 62 (2003) 591-595
6. Stein J.P. Indications for early cystectomy. Semin Urol Oncol 18 (2000) 289-295
7. Schrier B.P., Hollander M.P., van Rhijn B.W., et al. Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy. Eur Urol 45 (2004) 292-296
8. Hassan J.M., Cookson M.S., Smith Jr. J.A., et al. Outcomes in patients with pathological carcinoma in situ only disease at radical cystectomy. J Urol 172 (2004) 882-884
9. Lotan Y., Gupta A., Shariat S.F., et al. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 23 (2005) 6533-6539
10. Cookson M.S., Herr H.W., Zhang Z.F., et al. The treated natural history of high risk superficial bladder cancer: 15-year outcome. J Urol 158 (1997) 62-67
11. Spruck III C.H., Ohneseit P.F., Gonzalez-Zulueta M., et al. Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 54 (1994) 784-788
12. Millan-Rodriguez F., Chechile-Toniolo G., Salvador-Bayarri J., et al. Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol 163 (2000) 73-78
13. Shariat S.F., Pahlavan S., Baseman A.G., et al. E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder. Urology 57 (2001) 60-65
14. Shariat S.F., Kim J., Raptidis G., et al. Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladder. Urology 61 (2003) 1140-1145
15. Shariat S.F., Kim J.H., Ayala G.E., et al. Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder. J Urol 169 (2003) 938-942
16. Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19 (2001) 666-675
17. Amling C.L., Thrasher J.B., Frazier H.A., et al. Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder. J Urol 151 (1994) 31-36
18. Nixon R.G., Chang S.S., Lafleur B.J., et al. Carcinoma in situ and tumor multifocality predict the risk of prostatic urethral involvement at radical cystectomy in men with transitional cell carcinoma of the bladder. J Urol 167 (2002) 502-505